Clinical Studies

The Eye Institute of Utah specializes in comprehensive Pharmaceutical and Medical Device clinical trials. We are also actively involved in global research and development of diagnostic equipment, alongside investigator-initiated studies. Our clinical studies focus on assessing the safety and effectiveness of new devices, medications, and procedures for treating various ocular conditions.

Inquire About Clinical Studies

How Do Clinical Trials Benefit Our Patients?

As a participant, you will have access to state-of-the-art technologies and treatments before they are commercially available, allowing you to experience these innovative advancements firsthand. Our site has been a pioneer in introducing various treatments that are now widely adopted within the ophthalmology community. Our state-of-the-art clinic and surgical facilities are fully equipped to provide services such as laser vision correction, retina-vitreous care, glaucoma treatment, and cataract surgery, all under one roof.

Our Clinical Research Team

Our team includes three principal investigators and three sub-investigators on-site, with research experience spanning 5 to over 40 years. These investigators are highly skilled, well-trained in Good Clinical Practices (GCP), and knowledgeable about the FDA Code of Regulations. Established in 1980 as the first and largest office-based eye surgical center in Utah, The Eye Institute of Utah draws the majority of its study patients from our own patient population.

Our study department is supported by a dedicated team of full-time Clinical Research Coordinators and Research Technicians. Our mission is to deliver exceptional support to our community, sponsors, and patients, prioritizing patient safety and confidentiality. We are committed to excellence in clinical research, ensuring the highest quality work with integrity and efficiency. By investing in clinical research, we strive to enhance the quality of eye care for generations to come.

Current Clinical Studies

NCT04553523: Hydrus® Microstent Study

The purpose of this post-approval study is to evaluate the rate of Hydrus Microstent malposition and associated clinical sequelae occurring within 24 months post-operation. Qualified subjects will undergo uncomplicated cataract surgery with placement of a monofocal intraocular lens (IOL), followed by implantation of the Hydrus Microstent.

  • Sponsor: Alcon Research
  • Principal Investigator: Kristin O. Bretz, MD
  • Clinicaltrials.gov
  • Status: Open to enrollment

NCT06605638: Galaxy Rayner (WR-2021-US-01) Investigational Study

Premium IOL Study: Clinical trial to investigate the safety and effectiveness of a hydrophilic multifocal intraocular lens RayOne Galaxy RAO605G in comparison with a monofocal intraocular lens (RAO600C).

  • Sponsor: Rayner
  • Principal Investigator: Dr. Zachary J. Zavodni, MD 
  • Status: Open to Enrollment

Investigator-Initiated Trial

Refractive outcomes utilizing two SS-OCT Biometers for IOL power calculations.

  • Principal Investigator: Dr. Zachary J. Zavodni, MD 
  • Status: Open to Enrollment (expected duration month of January)

NCT06120842: Bimatoprost Implant System and SpyGlass IOL Study

Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution (Tigris) – This trial is a randomized study to evaluate and compare two doses of the Bimatoprost Implant System used in combination with the SpyGlass IOL to Timolol Ophthalmic Solution in participants with mild to moderate open-angle glaucoma or ocular hypertension undergoing cataract surgery.

  • Sponsor: SpyGlass Pharma, Inc.
  • Principal Investigator: Zachary J. Zavodni, MD
  • Clinicaltrials.gov
  • Status: Enrollment Now CLOSED

NCT05024695: MINIject Implant Study

Evaluate the Safety and Effectiveness of iSTAR Medical’s MINIject Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma. (STAR-V) – Evaluate the safety and effectiveness of iSTAR Medical’s MINIject implant for lowering intraocular pressure (IOP) in subjects with primary open-angle glaucoma.

  • Sponsor: iSTAR Medical
  • Principal Investigator: Kristin O. Bretz, MD
  • Clinicaltrials.gov
  • Status: Open to enrollment

Please check back for future dry eye disease clinical trials.

Please check back for future refractive surgery clinical trials.

NCT06542497: Presbyopia study (eye drop) OPI-NYXP-302 (VEGA-3)

Evaluate Efficacy and Safety of Phentolamine Ophthalmic Solution (POS) to Improve Distance-corrected Near Visual in Participants With Presbyopia (VEGA-3). 

  • Status: Open to enrollment
  • Sponsor: Ocuphire Pharma, Inc.
  • Principal Investigator: Dr. Randy B. Carter, OD
  • Clinicaltrials.gov

Please check back for future corneal disease clinical trials.

To learn more about it and find out if you are a candidate, please fill out the form below or contact our Study Department at (801) 263-5735.

Contact Us About Clinical Studies

Studies & Research
Please share what types of studies you are interested in (check all that apply)
Text Alerts: Opt-in for timely notifications and exclusive deals delivered to your mobile device.
By submitting this form you consent to receive phone calls, text messages and emails from The Eye Institute of Utah. It is not a condition of purchasing any goods or services. You can opt out at any time, message/data rates may apply, and opting-in includes acceptance of the Privacy Policy and Terms of Use. Communications through this website or via email are not encrypted and are not necessarily secure. Use of the internet or email is for your convenience only, and by using them, you assume the risk of unauthorized use.
Terms

Page Updated:

The Eye Institute of Utah Doctors have either authored or reviewed and approved this content.